These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 4601846)

  • 1. Immunohistologic studies of carcinoma of the prostate. 3. Elution of interepithelial antibodies from carcinomatous human prostatic tissue following cryoprostatectomy.
    Ablin RJ; Gonder MJ; Soanes WA
    Oncology; 1974; 29(4):329-34. PubMed ID: 4601846
    [No Abstract]   [Full Text] [Related]  

  • 2. Elution of in vivo bound antiprostatic epithelial antibodies following multiple cryotherapy of carcinoma of prostate.
    Ablin RJ; Soanes WA; Gonder MJ
    Urology; 1973 Sep; 2(3):276-9. PubMed ID: 4127037
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunohistologic studies of carcinoma of the prostate. II. Antibodies to prostatic tissue.
    Ablin RJ; Soanes WA; Danaher J
    Z Immunitatsforsch Exp Klin Immunol; 1972; 142(5):432-8. PubMed ID: 4258921
    [No Abstract]   [Full Text] [Related]  

  • 4. Elution of cell-bound anti-prostatic epithelial antibodies after multiple cryotherapy of carcinoma of the prostate.
    Ablin RJ; Gonder MJ; Soanes WA
    Cryobiology; 1974 Jun; 11(3):218-21. PubMed ID: 4616800
    [No Abstract]   [Full Text] [Related]  

  • 5. Antibodies reactive with autologous prostatic tissue in adenocarcinoma of prostate.
    Ablin RJ; Danaher J; Soanes WA; Gonder MJ
    Urology; 1974 Apr; 3(4):491-3. PubMed ID: 4595717
    [No Abstract]   [Full Text] [Related]  

  • 6. Remission of metastatic lesions following cryosurgery in prostatic cancer: immunologic considerations.
    Soanes WA; Ablin RJ; Gonder MJ
    J Urol; 1970 Jul; 104(1):154-9. PubMed ID: 4987666
    [No Abstract]   [Full Text] [Related]  

  • 7. Antibodies to epithelium in benign prostatic hypertrophy and carcinoma of prostate. Exacerbation to hyperplasia and neoplasia and possible clue to cancer.
    Ablin RJ; Guinan P; Bush IM
    Urology; 1974 Mar; 3(3):373-5. PubMed ID: 4132104
    [No Abstract]   [Full Text] [Related]  

  • 8. Immuno-cryourogenital treatment of benign and malignant diseases of the prostate.
    Ablin RJ; Soanes WA; Gonder MJ
    Gerontol Clin (Basel); 1970; 12(5):302-13. PubMed ID: 4096938
    [No Abstract]   [Full Text] [Related]  

  • 9. Letter: Anti-epithelial antibodies and malignancy.
    Ablin RJ
    Lancet; 1973 Dec; 2(7843):1451. PubMed ID: 4128769
    [No Abstract]   [Full Text] [Related]  

  • 10. Prospects for cryo-immunotherapy in cases of metastasizing carcinoma of the prostate.
    Alblin RJ; Soanes WA; Gonder MJ
    Cryobiology; 1971 Jun; 8(3):271-9. PubMed ID: 5570410
    [No Abstract]   [Full Text] [Related]  

  • 11. Cryosurgery for prostatic carcinoma.
    Jones LW
    Urology; 1974 Nov; 4(5):499-503. PubMed ID: 4610956
    [No Abstract]   [Full Text] [Related]  

  • 12. Serum proteins in prostatic cancer. V. Alterations in immunoglobulins and clinical responsiveness following cryoprostatectomy.
    Ablin RJ; Soanes WA; Gonder MJ
    Urol Int; 1977; 32(1):56-64. PubMed ID: 888251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunological surveillance and -globulin.
    Ablin RJ
    Isr J Med Sci; 1973 Apr; 9(4):480-3. PubMed ID: 4122703
    [No Abstract]   [Full Text] [Related]  

  • 14. Humoral immunity following double-freezing of the prostate in patients with prostatic cancer.
    Fushimi N; Jinno H; Washida H; Ueda K; Otaguro K
    Cryobiology; 1982 Jun; 19(3):242-6. PubMed ID: 6179717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cryoprostatectomy of prostatic tumors].
    Hikichi Y
    Gan No Rinsho; 1985 May; 31(6 Suppl):721-8. PubMed ID: 3897621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cryotherapy of rectal cancer. Immunologic results].
    Kogel H; Grundmann R; Fohlmeister I; Pichlmaier H
    Zentralbl Chir; 1985; 110(2-3):147-54. PubMed ID: 2580402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Artificial prostate-specific antigen persistence after radical prostatectomy.
    Poyet C; Hof D; Sulser T; Müntener M
    J Clin Oncol; 2012 Feb; 30(5):e62-3. PubMed ID: 22203757
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunologic responsiveness & tumour growth of the Dunning R3327 rat prostatic adenocarcinoma following cryosurgery & orchiectomy.
    Eskandari H; Ablin RJ; Bhatti RA
    Indian J Exp Biol; 1982 Dec; 20(12):872-4. PubMed ID: 7183523
    [No Abstract]   [Full Text] [Related]  

  • 19. [Prostate-specific antigen. A new biological serum marker for prostatic adenocarcinoma].
    Haukaas S; Skaarland E; Halvorsen OJ; Stensland E; Farstad M
    Tidsskr Nor Laegeforen; 1990 Sep; 110(23):2990-3. PubMed ID: 1700496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and experimental considerations of the immunologic response to prostatic and other accessory glands tissues of reproduction.
    Ablin RJ; Soanes WA; Gonder MJ
    Urol Int; 1970; 25(5):511-39. PubMed ID: 4111980
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.